Utility of 18F-Flurpiridaz PET Relative Flow Reserve in Differentiating Obstructive from Nonobstructive Coronary Artery Disease

作者：Diana M. Lopez, D. Huck, S. Divakaran, Jenifer M. Brown, Brittany N. Weber, M. Lemley, V. Builoff, A. Shanbhag, Lan Zhou, C. Buckley, M. Al-Mallah, S. Dorbala, R. Blankstein, P. Slomka, M. D. Di Carli · 发表于：Circulation Cardiovascular Imaging · 年份：2025 · DOI：10.1161/circimaging.125.018323 · 被引用次数：3 · 研究领域：Medicine

Background: Absolute quantification of myocardial blood flow (MBF) on PET perfusion imaging improves the identification of coronary artery disease (CAD). However, distinguishing MBF impairment due to obstructive CAD from nonobstructive CAD remains challenging. We aimed to evaluate the incremental diagnostic value of PET-derived relative flow reserve (RFR) in the diagnosis of obstructive CAD. Methods: This is a post hoc analysis of the multicenter phase-III trial of 18F-flurpiridaz PET (NCT01347710). Patients with available MBF quantification were included. Reduced stress MBF (sMBF) was defined as sMBF below the median (2.2 mL/min/g). Obstructive CAD on quantitative invasive coronary angiography (ICA) was defined as ≥70% stenosis. RFR was calculated as a ratio of the minimal segment sMBF over the highest reference vascular territory sMBF. RFR performance for predicting obstructive CAD was evaluated through Receiver Operating Characteristic (ROC) analysis and the net reclassification index (NRI) of multivariable regression models. Results: The study included 231 patients (71% male; 56% with established CAD) drawn from the original cohort of 755 trial participants. No patients had three-vessel CAD. In a per vessel-based analysis, 82% of vessels with reduced sMBF had no obstructive CAD on ICA. RFR was significantly lower for vessels with obstructive CAD (0.55 vs 0.80, p<0.0001). In vessels with reduced sMBF, RFR was independently associated with obstructive CAD even after account...